Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Idelvion for the Treatment of Haemophilia B

Drug (Brand/Generic)

IDELVION (Coagulation Factor IX (Recombinant), Albumin Fusion Protein)

Company

CSL Behring

Therapy Class

Albumin fusion protein

Current Indication

Haemophilia B

Development status

Approved in the US, Europe and Canada
Expand

Go Top